candesartan cilexetil

Also found in: Medical, Wikipedia.

can·de·sar·tan ci·lex·e·til

 (kăn′də-sär′tn sĭ-lĕk′sə-tĭl′)
An angiotensin II receptor blocker drug, C33H34N6O6, used to treat hypertension and heart failure.

[cande-, of unknown origin + -sartan, angiotensin II receptor blocker suff.; see losartan + cilexetil (shortening and alteration of cyclohexyloxycarbonyloxy ethyl ester).]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
References in periodicals archive ?
Brand products: BLOPRESS (Candesartan Cilexetil) Tablets 2 mg, 4 mg, 8 mg and 12 mg
The rats were randomly divided into four groups (n = 8): negative control group (distilled water), TAA (positive control) group, candesartan cilexetil group (0.2 mg/kg/day) (Gaur & Kumar, 2011), and losartan potassium group (7.5 mg/kg/day) (Croquet et al., 2002).
AstraZeneca Plc (LSE:AZ), a global, science-led biopharmaceutical company, announced on Monday the completion of an agreement with Cheplapharm Arzneimittel GmbH (Cheplapharm) for the commercial rights to Atacand (candesartan cilexetil) and Atacand Plus (fixed-dose combination of candesartan cilexetil and hydrochlorothiazide) for 28 countries in Europe.
The Acute Candesartan Cilexetil Therapy in Stroke Survivors study showed that in the acute phase of stroke, RAS inhibition can lead to brain protection irrespective of its hypotensive effect.
Kawamori, and Candesartan in Diabetic Nephropathy Study Group, "Antiproteinuric effect of candesartan cilexetil in Japanese subjects with type 2 diabetes and nephropathy," Diabetes Research and Clinical Practice, vol.
The TAA-CLF rats were randomly divided into five groups (n=8) treated once daily for 14 days by gastric gavage as follows: distilled water (control group), 5 (L5) and 10 mg/kg (L10) losartan potassium groups (14) and 0.1 (C0.1) and 0.3 (C0.3) mg/kg candesartan cilexetil groups (15).
His past medical history was positive only for previous cochlear implant in 2005 and hypertension in treatment with candesartan cilexetil and hydrochlorothiazide.
Effects of orally applied candesartan cilexetil on central responses to angiotensin II in conscious rats.
Bu et al., "Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: performance and mechanism," Journal of Controlled Release, vol.
In support of these observations, candesartan cilexetil [105] and losartan improve renal hemodynamic and insulin resistance [106] and lower blood pressure in diabetic rodents fed a high fructose diet [107] presumably by the activation of AMP-activated protein kinase [108].
The safety and tolerability of candesartan cilexetil in CHF.